Celgene Corp. buy melinda
Start price
11.10.13
/
50%
€56.45
Target price
23.12.13
€60.00
Performance (%)
9.27%
End price
23.12.13
€61.68
Summary
This prediction ended on 23.12.13 with a price of €61.68. The BUY prediction by melinda finished with a performance of 9.27%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -1,42 % | 8,92 % | 7,31 % | 49,21 % |
| iShares Nasdaq 100 | 3,27 % | 16,28 % | 36,65 % | 97,34 % |
| iShares Nikkei 225® | 1,75 % | 16,24 % | 46,60 % | 64,98 % |
| iShares S&P 500 | 1,45 % | 10,91 % | 27,17 % | 68,77 % |
Comments by melinda for this prediction
In the thread Celgene Corp. diskutieren
erhöhen
RBC Capital Markets